Phantom limbs and related phenomena in recent traumatic amputations

作者
Peter L. Carlen,Patrick D. Wall,H Nadvorna,T Steinbach
出处
期刊:Neurology [Lippincott Williams & Wilkins]
卷期号:28 (3): 211-211 被引量:278
标识
DOI:10.1212/wnl.28.3.211
摘要

Introduction Venous sinus stenting (VSS) has emerged as an alternative treatment for idiopathic intracranial hypertension (IIH) patients with evidence of transverse-sigmoid stenosis and symptoms refractory to medical therapy. Though its efficacy in alleviating visual deficits, papilledema, headache and nausea is promising, a substantial rate of restenosis can occur either within or adjacent to the stented segment. It is possible that increase of, or failure to lose, body-weight could potentially be a mechanism behind restenosis, as central venous pressure would remain elevated. We report IIH patients who underwent VSS at our institution and compare characteristics between those with and without restenosis, focusing on patient’s body mass index (BMI). Methods Our institution’s database was retrospectively analyzed. We included all IIH patients who underwent VSS between January 2021 March 2022. Analysis between restenosis and non-restenosis groups was performed. Body mass index was evaluated as a continuous variable and also as categorical by stratification into normal (<25), overweight (25–29.9), obesity class I (30–34.9), obesity class II (35–39.9), obesity class III (≥40). BMI groups were dichotomized into normal or mildly obese (normal, overweight and obesity class I) and moderate to severely obese (obesity classes II and III). Results A total of 55 patients were included, of which 7 (12.7%) had restenosis. Age, sex, and comorbidities were similar between non-restenosis and restenosis patients. Opening pressure on lumbar puncture was similar between the groups (non-restenosis, 35.1 vs restenosis, 38.1, P=0.304). Median BMI at time of procedure was similar between the groups (non-restenosis, 35.1 vs non-restenosis, 37.1, P=0.958). Median pre-stenting pressure gradient was not significantly different between the groups (non-restenosis, 17 vs restenosis, 21, P=0.280), and neither was immediate post-stenting pressure gradient (non-restenosis, 1 vs restenosis, 3, P=0.230). Median time of follow-up was not significantly different between the groups (non-restenosis, 676 days vs restenosis, 597 days, P=0.319). Median BMI at last follow-up or at date of restenosis detection was not significantly different between the groups (non-restenosis, 36.1 vs restenosis, 36.5, P=0.904). Neither stratification nor dichotomization of BMI revealed differences between the groups. Median BMI change from procedure to last follow-up was not different between the groups (non-restenosis, 0.1 vs restenosis, 0, P=0.552). Reduction in BMI class was also not different between the groups (non-restenosis, 12.5% vs restenosis, 28.6%, P=0.645). Conclusions Idiopathic intracranial hypertension patients with venous sinus stenosis treated with VSS who had restenosis were similar to those who did not with regards to demographics, pressure gradients and duration of follow-up. Body mass index did not predict restenosis as we hypothesized. Disclosures J. Cappuzzo: None. A. Monteiro: None. N. Siddiqi: None. A. Baig: None. W. Khawar: None. B. Donnelly: None. S. Housley: None. M. Waqas: None. E. Levy: 2; C; Claret Medical, GLG Consulting, Guidepoint Global, Imperial Care, Medtronic, Rebound, StimMed, Misionix, Mosiac, Clarion, IRRAS. 4; C; NeXtGen Biologics, RAPID Medical, Claret Medical, Cognition Medical, Imperative Care, Rebound Therapeutics, StimMed, Three Rivers Medical. A. Siddiqui: 2; C; Amnis Therapeutics, Apellis Pharmaceuticals, Inc., Boston Scientific, Canon Medical Systems USA, Inc., Cardinal Health 200, LLC, Cerebrotech Medical Systems, Inc., Cerenovus, Cerevatech Medical, Inc.,. 4; C; Adona Medical, Inc., Amnis Therapeutics, Bend IT Technologies, Ltd., BlinkTBI, Inc, Buffalo Technology Partners, Inc., Cardinal Consultants, LLC, Cerebrotech Medical Systems, Inc, Cerevatech Medical.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
爆米花的应助被科研通管家采纳,获得10
刚刚
小蘑菇的应助被科研通管家采纳,获得10
刚刚
共享精神的应助被科研通管家采纳,获得10
1秒前
威fly完成签到,获得积分10
1秒前
dxxxxx完成签到,获得积分10
1秒前
Hello的应助被科研通管家采纳,获得10
1秒前
CodeCraft的应助被科研通管家采纳,获得10
1秒前
ding的应助被科研通管家采纳,获得10
1秒前
ymorningrock发布了新的文献求助10
1秒前
1秒前
1秒前
SciGPT的应助被科研通管家采纳,获得10
1秒前
大聪明发布了新的文献求助10
2秒前
2秒前
2秒前
2秒前
2秒前
钟梓袄发布了新的文献求助10
3秒前
互助完成签到,获得积分0
3秒前
自信诗桃发布了新的文献求助10
3秒前
欣q完成签到 ,获得积分10
3秒前
3秒前
yi发布了新的文献求助10
3秒前
RUI发布了新的文献求助10
3秒前
orixero的应助被Miraitowa采纳,获得10
4秒前
4秒前
qin202569发布了新的文献求助10
4秒前
lyb发布了新的文献求助10
4秒前
5秒前
wanci的应助被哎哟可爱采纳,获得10
5秒前
5秒前
老实灵安完成签到,获得积分10
6秒前
温暖砖头发布了新的文献求助10
6秒前
英勇冰淇淋完成签到 ,获得积分10
6秒前
迷路的灵波的应助被SKHC采纳,获得10
6秒前
遇事不慌张女士完成签到,获得积分20
7秒前
7秒前
慕青的应助被1097采纳,获得10
7秒前
可爱的函函的应助被无敌啊豹采纳,获得10
8秒前
追寻的梦岚完成签到,获得积分20
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183142
求助须知:如何正确求助?哪些是违规求助? 9572420
关于积分的说明 21825253
捐赠科研通 7779922
什么是DOI,文献DOI怎么找? 3433850
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480124